Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HTR6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC39A10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
DHRS4-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VEZT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDLIM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KATNAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELLS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THSD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5F1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on